Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priscilla K Yen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2021
ReplyJeffrey R Curtis, Elaine Karis, Priscilla K Yen, et al.
The Journal of Rheumatology|April 15, 2023
Factors Associated With Maintenance of Remission Following Change From Combination Therapy to Monotherapy in Patients With Rheumatoid ArthritisJeffrey R Curtis, Paul Emery, Greg Kricorian, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 18, 2020
Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained RemissionJeffrey R Curtis, Paul Emery, Elaine Karis, et al.
Vascular Medicine (London, England)|September 21, 2013
n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trialS Marlene Grenon, Christopher D Owens, Hugh Alley, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 2, 2022
Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis: Results From the SEAM-RA TrialJeffrey R Curtis, Bradley Stolshek, Paul Emery, et al.
AIDS (London, England)|February 10, 2018
A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphomaMarta Epeldegui, Larry Magpantay, Yu Guo, et al.
Journal of the American Heart Association|August 23, 2015
Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial)S Marlene Grenon, Christopher D Owens, Emily V Nosova, et al.
Rheumatology (Oxford, England)|September 1, 2020
Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritisLaura C Coates, Joseph F Merola, Philip J Mease, et al.
Leukemia & Lymphoma|May 7, 2024
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation studyFarhad Ravandi, Marion Subklewe, Roland B Walter, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2021
ReplyJeffrey R Curtis, Elaine Karis, Priscilla K Yen, et al.
The Journal of Rheumatology|April 15, 2023
Factors Associated With Maintenance of Remission Following Change From Combination Therapy to Monotherapy in Patients With Rheumatoid ArthritisJeffrey R Curtis, Paul Emery, Greg Kricorian, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 18, 2020
Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained RemissionJeffrey R Curtis, Paul Emery, Elaine Karis, et al.
Vascular Medicine (London, England)|September 21, 2013
n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trialS Marlene Grenon, Christopher D Owens, Hugh Alley, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 2, 2022
Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis: Results From the SEAM-RA TrialJeffrey R Curtis, Bradley Stolshek, Paul Emery, et al.
AIDS (London, England)|February 10, 2018
A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphomaMarta Epeldegui, Larry Magpantay, Yu Guo, et al.
Journal of the American Heart Association|August 23, 2015
Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial)S Marlene Grenon, Christopher D Owens, Emily V Nosova, et al.
Rheumatology (Oxford, England)|September 1, 2020
Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritisLaura C Coates, Joseph F Merola, Philip J Mease, et al.
Leukemia & Lymphoma|May 7, 2024
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation studyFarhad Ravandi, Marion Subklewe, Roland B Walter, et al.
Pageof 1